Petros Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)13holders
$1.48avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Petros Pharmaceuticals Inc. in their 13F filings. The largest holders were Vanguard Group Inc. ($47K), BlackRock Inc. ($24K) and Geode Capital Management, LLC ($16K).
- Company
- Petros Pharmaceuticals Inc.
- CUSIP
- 71678J209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $198 |
| Exits | 4 | $67K |
Ownership 13 holders
| Vanguard Group Inc. | 0.00% | No change | 31,811 | $47K |
| BlackRock Inc. | 0.00% | Reduce -0.5% | 16,510 | $24K |
| Geode Capital Management, LLC | 0.00% | No change | 10,502 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -62.8% | 3,395 | $5K |
| Emfo, LLC | 0.00% | No change | 1,000 | $1K |
| Morgan Stanley | 0.00% | Add +2578.9% | 509 | $753 |
| National Bank of Canada | 0.00% | New | 313 | $198 |
| NFSG Corp | 0.00% | No change | 120 | $178 |
| Group One Trading LLC | 0.00% | No change | 79 | $117 |
| Osaic Holdings, Inc. | 0.00% | No change | 14 | $21 |
| Wells Fargo & Company | 0.00% | No change | 12 | $18 |
| 1832 Asset Management L.P. | 0.00% | No change | 10 | $15 |
| Bank of America Corp. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is PETROS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Petros Pharmaceuticals Inc. the manager owns.